ALMUS ALLERGY RELIEF

Posology Do not exceed the stated dose or the frequency of dosing. The minimum interval between doses should be 4 hours. Do not use continuously for more than two weeks without consulting a doctor. Adults and children 12 years and over: 10 ml (4 mg) every 4 - 6 hourly.

Maximum daily dose: 60 ml (24 mg) in any 24 hours.

Elderly:

The elderly are more likely to experience neurological anticholinergic effects. g. a maximum of 12 mg in any 24 hours). Children aged 6 - 12 years: 5 ml (2 mg) every 4 - 6 hourly. Maximum daily dose: 30 ml (12 mg) in 24 hours. 5 ml (1 mg) every 4 - 6 hourly.

Maximum daily dose: 15 ml (6 mg) in 24 hours. 5 ml (1 mg) twice daily. The minimum interval between the doses should be 4 hours. Maximum daily dose: 5 ml (2 mg) in any 24 hours. Not recommended for children below 1 year Populations Patients with renal or hepatic impairment should seek doctor’s advice prior to taking this medicine.

(See section

The following convention has been utilised for the classification of the frequency of adverse reactions: very common (>1/10), common (>1/100 to <1/10), uncommon (>1/1000 to <1/100), rare (>1/10,000 to <1/1000) and very rare (<1/10,000), not known (cannot be estimated from available data).

Adverse reactions identified during post-marketing use with chlorphenamine are listed below. g. increased energy, restlessness, nervousness). Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important.

It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard) or search for MHRA Yellow Card in the Google Play or Apple App Store.

). Method of administration For oral administration. 1. Chlorphenamine is contraindicated in patients who have had treatment with monoamine Oxidase Inhibitors (MAOI’s) within the last 14 days as the anticholinergic properties of chlorphenamine are intensified by MAOI’s.

4 Special warnings and precautions for use Chlorphenamine has an anticholinergic effects and should be used with caution in patients with epilepsy, raised intra-ocular pressure including glaucoma, prostatic hypertrophy, severe hypertension, cardiovascular disease, bronchitis, bronchiectasis, asthma, hepatic impairment and renal impairment.

g. increased energy, restlessness, nervousness). Avoid use in elderly patients with confusion. The anticholinergic properties of chlorphenamine may cause drowsiness, dizziness, blurred vision and psychomotor impairment in some patients which may seriously affect ability to drive and use machinery.

The effects of alcohol may be increased and therefore should be avoided. Chlorphenamine should not be used with other antihistamine containing products such as antihistamine containing cough and cold medicines. Concurrent use with drugs which cause sedation such as anxiolytics and hypnotics may cause an increase in sedative effects, therefore medical advice should be sought before taking chlorphenamine concurrently with these medicines.

Patients with rare hereditary problems of fructose intolerance should not take this medicine.

1. Chlorphenamine is contraindicated in patients who have had treatment with monoamine Oxidase Inhibitors (MAOI’s) within the last 14 days as the anticholinergic properties of chlorphenamine are intensified by MAOI’s.